BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38523520)

  • 1. A Radiomics-clinical Nomogram based on CT Radiomics to Predict Acquired T790M Mutation Status in Non-small Cell Lung Cancer Patients.
    Xiong W; Yu X; Zhou T; Huang H; Zhao Z; Wang T
    Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38523520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can CT Radiomics Detect Acquired T790M Mutation and Predict Prognosis in Advanced Lung Adenocarcinoma With Progression After First- or Second-Generation EGFR TKIs?
    Yang X; Fang C; Li C; Gong M; Yi X; Lin H; Li K; Yu X
    Front Oncol; 2022; 12():904983. PubMed ID: 35875167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based nomogram for early identification of T790M resistance in metastatic non-small cell lung cancer before first-line epidermal growth factor receptor-tyrosine kinase inhibitors therapy.
    Li Y; Lv X; Wang Y; Xu Z; Lv Y; Hou D
    Eur Radiol Exp; 2023 Nov; 7(1):64. PubMed ID: 37914925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With
    Tang X; Li Y; Yan WF; Qian WL; Pang T; Gong YL; Yang ZG
    Front Oncol; 2021; 11():719919. PubMed ID: 34660285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT Radiomics Predict EGFR-T790M Resistance Mutation in Advanced Non-Small Cell Lung Cancer Patients After Progression on First-line EGFR-TKI.
    Tang X; Li Y; Shen LT; Yan WF; Qian WL; Yang ZG
    Acad Radiol; 2023 Nov; 30(11):2574-2587. PubMed ID: 36941156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC.
    Lu J; Ji X; Liu X; Jiang Y; Li G; Fang P; Li W; Zuo A; Guo Z; Yang S; Ji Y; Lu D
    Sci Rep; 2024 Jan; 14(1):446. PubMed ID: 38172228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in Lung Cancer Patients.
    Kong C; Lai L; Jin X; Chen W; Ding J; Zheng L; Zhang D; Ying X; Chen X; Chen M; Tu J; Ji J
    Acad Radiol; 2023 Dec; 30(12):2880-2893. PubMed ID: 37225529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
    Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
    Front Oncol; 2019; 9():1485. PubMed ID: 31993370
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature.
    Qian LD; Zhang SX; Li SQ; Feng LJ; Zhou ZA; Liu J; Zhang MY; Yang JG
    Insights Imaging; 2023 Nov; 14(1):205. PubMed ID: 38001240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization.
    Dong W; Xiong S; Lei P; Wang X; Liu H; Liu Y; Zou H; Fan B; Qiu Y
    Front Oncol; 2022; 12():944005. PubMed ID: 36081562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.
    Yang X; Liu M; Ren Y; Chen H; Yu P; Wang S; Zhang R; Dai H; Wang C
    Eur Radiol; 2022 Apr; 32(4):2693-2703. PubMed ID: 34807270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.
    Fan Y; Dong Y; Wang H; Wang H; Sun X; Wang X; Zhao P; Luo Y; Jiang X
    Eur Radiol; 2022 Oct; 32(10):6739-6751. PubMed ID: 35729427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting
    Zhang G; Cao Y; Zhang J; Ren J; Zhao Z; Zhang X; Li S; Deng L; Zhou J
    Am J Cancer Res; 2021; 11(2):546-560. PubMed ID: 33575086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.
    Fan Y; Wang X; Yang C; Chen H; Wang H; Wang X; Hou S; Wang L; Luo Y; Sha X; Yang H; Yu T; Jiang X
    J Magn Reson Imaging; 2023 Dec; 58(6):1838-1847. PubMed ID: 37144750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a CT radiomics nomogram for preoperative prediction of Ki-67 index in pancreatic ductal adenocarcinoma: a two-center retrospective study.
    Li Q; Song Z; Li X; Zhang D; Yu J; Li Z; Huang J; Su K; Liu Q; Zhang X; Tang Z
    Eur Radiol; 2024 May; 34(5):2934-2943. PubMed ID: 37938382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients.
    Li Q; Song Z; Zhang D; Li X; Liu Q; Yu J; Li Z; Zhang J; Ren X; Wen Y; Tang Z
    Front Oncol; 2022; 12():992906. PubMed ID: 36276058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.
    Hong D; Xu K; Zhang L; Wan X; Guo Y
    Front Oncol; 2020; 10():28. PubMed ID: 32082997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.